108 related articles for article (PubMed ID: 29545395)
1. Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.
Nakamura T; Zhu G; Ranek MJ; Kokkonen-Simon K; Zhang M; Kim GE; Tsujita K; Kass DA
Circ Heart Fail; 2018 Mar; 11(3):e004740. PubMed ID: 29545395
[TBL] [Abstract][Full Text] [Related]
2. PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy.
Escudero DS; Brea MS; Caldiz CI; Amarillo ME; Aranda JO; Portiansky EL; Pérez NG; Díaz RG
Eur J Pharmacol; 2021 Jan; 891():173724. PubMed ID: 33152335
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
[TBL] [Abstract][Full Text] [Related]
4. Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.
Rudyk O; Eaton P
Free Radic Biol Med; 2017 Sep; 110():390-398. PubMed ID: 28690194
[TBL] [Abstract][Full Text] [Related]
5. Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1α knock-in mouse.
Rudyk O; Prysyazhna O; Burgoyne JR; Eaton P
Circulation; 2012 Jul; 126(3):287-95. PubMed ID: 22685118
[TBL] [Abstract][Full Text] [Related]
6. PDE5 inhibitor sildenafil attenuates cardiac microRNA 214 upregulation and pro-apoptotic signaling after chronic alcohol ingestion in mice.
Samidurai A; Xi L; Salloum FN; Das A; Kukreja RC
Mol Cell Biochem; 2020 Aug; 471(1-2):189-201. PubMed ID: 32535704
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of cysteine 117 stimulates constitutive activation of the type Iα cGMP-dependent protein kinase.
Sheehe JL; Bonev AD; Schmoker AM; Ballif BA; Nelson MT; Moon TM; Dostmann WR
J Biol Chem; 2018 Oct; 293(43):16791-16802. PubMed ID: 30206122
[TBL] [Abstract][Full Text] [Related]
8. Chronic circadian rhythm disorder induces heart failure with preserved ejection fraction-like phenotype through the Clock-sGC-cGMP-PKG1 signaling pathway.
Che Y; Shimizu Y; Hayashi T; Suzuki J; Pu Z; Tsuzuki K; Narita S; Shibata R; Murohara T
Sci Rep; 2024 May; 14(1):10777. PubMed ID: 38734687
[TBL] [Abstract][Full Text] [Related]
9. PDE5 inhibition mitigates heart failure in hyperlipidemia.
Huang W; Yang X; Zhang N; Chen K; Xiao J; Qiu Z; You S; Gao Z; Ji J; Chen L
Biomed Pharmacother; 2024 Jun; 175():116710. PubMed ID: 38713942
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional Sildenafil Diazeniumdiolates Acting as Phosphodiesterase 5 Inhibitors and Nitric Oxide Donors- Towards Wound Healing.
Mas-Roselló J; Tenor H; Szabo T; Naef R; Sieber S; Gademann K
Chembiochem; 2024 Apr; 25(8):e202300801. PubMed ID: 38430555
[TBL] [Abstract][Full Text] [Related]
11. Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.
Korkmaz-Icöz S; Radovits T; Szabó G
Br J Pharmacol; 2018 Jan; 175(2):223-231. PubMed ID: 28213937
[TBL] [Abstract][Full Text] [Related]
12. Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?
Michalak M; Armstrong PW
Circ Heart Fail; 2018 Mar; 11(3):e004813. PubMed ID: 29545396
[No Abstract] [Full Text] [Related]
13. Endothelium-derived hyperpolarizing factor and protein kinase G Iα activation: H
Bautista-Niño PK; van der Stel M; Batenburg WW; de Vries R; Roks AJM; Danser AHJ
Eur J Pharmacol; 2018 May; 827():112-116. PubMed ID: 29550336
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil ameliorates right ventricular early molecular derangement during left ventricular pressure overload.
Imai Y; Kariya T; Iwakiri M; Yamada Y; Takimoto E
PLoS One; 2018; 13(4):e0195528. PubMed ID: 29621314
[TBL] [Abstract][Full Text] [Related]
15. An N-terminally truncated form of cyclic GMP-dependent protein kinase Iα (PKG Iα) is monomeric and autoinhibited and provides a model for activation.
Moon TM; Sheehe JL; Nukareddy P; Nausch LW; Wohlfahrt J; Matthews DE; Blumenthal DK; Dostmann WR
J Biol Chem; 2018 May; 293(21):7916-7929. PubMed ID: 29602907
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease.
Tobin JV; Zimmer DP; Shea C; Germano P; Bernier SG; Liu G; Long K; Miyashiro J; Ranganath S; Jacobson S; Tang K; Im GJ; Sheppeck J; Moore JD; Sykes K; Wakefield J; Sarno R; Banijamali AR; Profy AT; Milne GT; Currie MG; Masferrer JL
J Pharmacol Exp Ther; 2018 Jun; 365(3):664-675. PubMed ID: 29643251
[TBL] [Abstract][Full Text] [Related]
17. A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing.
Prasanna G; Ferrara L; Adams C; Ehara T; Li B; Yang L; Xiang C; Ng CTH; Kim S; Towler C; Topley T; McAllister C; Ghosh M; Newton R; Stacy R; Rice DS; Mogi M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1704-1716. PubMed ID: 29610853
[TBL] [Abstract][Full Text] [Related]
18. Protein
Wang SB; Venkatraman V; Crowgey EL; Liu T; Fu Z; Holewinski R; Ranek M; Kass DA; O'Rourke B; Van Eyk JE
Circ Res; 2018 May; 122(11):1517-1531. PubMed ID: 29563102
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed Optical Imaging of Energy Substrates Reveals That Left Ventricular Hypertrophy Is Associated With Brown Adipose Tissue Activation.
Panagia M; Chen HH; Croteau D; Iris Chen YC; Ran C; Luptak I; Josephson L; Colucci WS; Sosnovik DE
Circ Cardiovasc Imaging; 2018 Mar; 11(3):e007007. PubMed ID: 29555834
[TBL] [Abstract][Full Text] [Related]
20. PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery.
Andersson KE
Br J Pharmacol; 2018 Jul; 175(13):2554-2565. PubMed ID: 29667180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
